ANNOVIS BIO INC's ticker is ANVS and the CUSIP is 03615A108. A total of 13 filers reported holding ANNOVIS BIO INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $94,900 | -33.6% | 10,000 | 0.0% | 0.00% | -40.0% |
| Q2 2023 | $142,900 | -7.3% | 10,000 | 0.0% | 0.01% | -16.7% |
| Q1 2023 | $154,100 | +14.7% | 10,000 | 0.0% | 0.01% | +20.0% |
| Q4 2022 | $134,300 | -2.0% | 10,000 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $137,000 | +21.2% | 10,000 | 0.0% | 0.01% | +25.0% |
| Q2 2022 | $113,000 | -15.7% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $134,000 | -23.9% | 10,000 | 0.0% | 0.00% | -20.0% |
| Q4 2021 | $176,000 | -65.8% | 10,000 | -38.3% | 0.01% | -68.8% |
| Q3 2021 | $514,000 | -62.5% | 16,200 | +1.2% | 0.02% | -61.0% |
| Q2 2021 | $1,369,000 | +390.7% | 16,000 | +60.0% | 0.04% | +355.6% |
| Q1 2021 | $279,000 | +272.0% | 10,000 | 0.0% | 0.01% | +350.0% |
| Q4 2020 | $75,000 | +56.2% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $48,000 | +9.1% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $44,000 | +46.7% | 10,000 | 0.0% | 0.00% | +100.0% |
| Q1 2020 | $30,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 463,797 | $3,497,000 | 1.42% |
| Worth Venture Partners, LLC | 119,538 | $901,000 | 0.71% |
| Lokken Investment Group LLC | 32,211 | $243,000 | 0.22% |
| Sterling Investment Advisors, Ltd. | 50,588 | $381,000 | 0.13% |
| Modera Wealth Management, LLC | 43,846 | $331,000 | 0.03% |
| Cannell & Co. | 10,000 | $75,000 | 0.00% |
| Sowell Financial Services LLC | 1,529 | $12,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| MORGAN STANLEY | 14,286 | $108,000 | 0.00% |
| BROWN ADVISORY INC | 14,942 | $113,000 | 0.00% |